Data layers Raw facts Calculated Model prediction AI interpretation

IPO Timeline Raw facts

Broker Deadline
Morning deadline
HKEX Deadline
Noon deadline
Broker Results (T-2)
Some brokers release in afternoon
Grey Market (T-1)
Afternoon
HKEX Allotment (T-1)
Evening
Registrar Allotment (T-1)
Evening
Listing Day (T)
First day of trading

Company Overview

Stock NameQingsong Health
Stock Code02661
Company Full NameQingSong Health Corp
IndustryHealthcare
Principal ActivitiesWe provide health-related and insurance-related solutions in China. According to data from the Frost & Sullivan report, based on 2024 revenue, we ranked 10th in the digital integrated health services and health insurance services market in China. Specifically, according to the same source, based on 2024 revenue, we ranked seventh in the digital health services market in China. We are committed to providing protection and support to those in need through a suite of easy-to-use, accurate and affordable health solutions.
Listing Date2025-12-23
Listing Rules EraNew Rules (after Aug 2025)
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國北京市東城區安定門東大街28號雍和大廈F座7層
Business Address (Hong Kong)To be extracted
Place of IncorporationCayman Islands
Listing MethodGlobal Offering
Listing BoardMain Board
Websiteqingsonghealth.com
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism B
Offer PriceHK$ 22.68 / shares
Offer Price RangeFinal offer price only, no range
Lot Size200 shares
Entry ThresholdHK$ 4,536
Par ValueRMB 0.0001 / shares
Offer Period2025-12-15 to 2025-12-18
Global Offering Shares26,540,000 shares
HK Public Offer Shares (Initial)2,654,000 shares (10.0%)
Public Offer Lots (Initial)13,270lots (Pool A6,635lots,Pool B6,635lots)
International Placing Shares (Initial)23,886,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO206,374,209 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)中国国际金融香港证券有限公司 CE AEN894
Cornerstone Share18.1%
Clawback TiersMechanism B: no clawback mechanism
Reallocation OptionNo
Total Global Offering SizeHK$ 601,927,200

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 200 HK$ 4,536
2 lots 400 HK$ 9,072
3 lots 600 HK$ 13,608
4 lots 800 HK$ 18,144
5 lots 1,000 HK$ 22,680
6 lots 1,200 HK$ 27,216
7 lots 1,400 HK$ 31,752
8 lots 1,600 HK$ 36,288
9 lots 1,800 HK$ 40,824
10 lots 2,000 HK$ 45,360
15 lots 3,000 HK$ 68,040
20 lots 4,000 HK$ 90,720
25 lots 5,000 HK$ 113,400
30 lots 6,000 HK$ 136,080
35 lots 7,000 HK$ 158,760
40 lots 8,000 HK$ 181,440
45 lots 9,000 HK$ 204,120
50 lots 10,000 HK$ 226,800
100 lots 20,000 HK$ 453,600
150 lots 30,000 HK$ 680,400
200 lots 40,000 HK$ 907,200
250 lots 50,000 HK$ 1,134,000
500 lots 100,000 HK$ 2,268,000
750 lots 150,000 HK$ 3,402,000
1,000 lots 200,000 HK$ 4,536,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1,250 lots 250,000 HK$ 5,670,000
1,500 lots 300,000 HK$ 6,804,000
1,750 lots 350,000 HK$ 7,938,000
2,000 lots 400,000 HK$ 9,072,000
2,250 lots 450,000 HK$ 10,206,000
2,500 lots 500,000 HK$ 11,340,000
2,750 lots 550,000 HK$ 12,474,000
3,000 lots 600,000 HK$ 13,608,000
3,500 lots 700,000 HK$ 15,876,000
4,000 lots 800,000 HK$ 18,144,000
4,500 lots 900,000 HK$ 20,412,000
5,000 lots 1,000,000 HK$ 22,680,000
5,500 lots 1,100,000 HK$ 24,948,000
6,000 lots 1,200,000 HK$ 27,216,000
6,635 lots 1,327,000 HK$ 30,096,360

Stock Connect Inclusion Analysis

HK Market Cap HK$ 8.08B
Analysis Result Already included in Stock Connect (both)

Valuation & Financials

Market Cap (at Offer Price)HK$ 4,680,000,000
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot applicable (loss-making)
Profit/Loss StatusNet profit RMB 9 million
Period-End Cash BalanceTo be extracted
Listing Expenses~HK$ 88,500,000
Listing Expenses / Funds Raised~14.7%
Total Pre-IPO InvestmentTo be extracted
First Day CloseHK$ 58.7
First Day OpenHK$ 50.0
First Day Change158.82%
First Day Volume6239600.0
First Day Turnover320167000.0
Use of Proceeds
1、約40.0%或205.4百萬港元,將用于提升品牌知名度、提高用戶參與度及加強與業務合作伙伴的合作; 2、約20.0%或102.7百萬港元,將用于醫學研究和真實世界研究; 3、約20.0%或102.7百萬港元,將用于提升在AI及大數據領域的技術能力,以便更廣泛應用于產品及服務; 4、約10.0%或51.3百萬港元,將用于拓展至更多地區及海外市場; 5、約10.0%或51.3百萬港元,用作營運資金及其他一般公司用途。

Underwriting Syndicate

Joint Sponsors (2)
中国国际金融香港证券有限公司 CE AEN894 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650
Overall Coordinators (2)
中国国际金融香港证券有限公司 CE AEN894 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650
Joint Global Coordinators (3)
中国国际金融香港证券有限公司 CE AEN894 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650 富途证券国际(香港)有限公司 CE AZT137
Joint Bookrunners (4)
中国国际金融香港证券有限公司 CE AEN894 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650 富途证券国际(香港)有限公司 CE AZT137 SPDB International Capital Limited CE BFZ375
Joint Lead Managers (4)
中国国际金融香港证券有限公司 CE AEN894 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650 富途证券国际(香港)有限公司 CE AZT137 SPDB International Capital Limited CE BFZ375
Capital Market Intermediaries (4)
中国国际金融香港证券有限公司 CE AEN894 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650 富途证券国际(香港)有限公司 CE AZT137 SPDB International Capital Limited CE BFZ375
Stabilizing Manager (1)
中国国际金融香港证券有限公司 CE AEN894

Service Providers

RoleInstitution
Legal Advisor to Company 贝克‧麦坚时律师事务所
Tian Yuan Law Firm
衡力斯律师事务所
通商律师事务所
Legal Advisor to Sponsors/Underwriters Herbert Smith Freehills Kramer
海问律师事务所
Auditor and Reporting Accountant 德勤‧关黄陈方会计师行
Industry Advisor 弗若斯特沙利文(北京)咨询有限公司上海分公司
Receiving Banks 招商永隆银行有限公司

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 广东横琴粤澳深度合作区澳琴合鸣投资合伙企业(有限合伙) 100,000,000 CNY 4,801,800 18.09% 2.33% 6 months 2026-06-23

Directors & Management

PositionChinese nameEnglish Name
Chairman / Executive Director杨胤YANGYin
Company Secretary楊磊,陳靜雅—
Non-Executive Director赵宇平ZHAOYuping
Independent Non-Executive Director王晓燕WANGXiaoyan
Executive Director王静WANGJing
Non-Executive Director郑凯还ZHENGKaihuan
Independent Non-Executive Director周耀明CHOWYiuMing
Non-Executive Director吴彬WUBin
Independent Non-Executive Director白昆BAIKun

Major Shareholders

Major Shareholders & HoldingsMs. Yang Yin controls approximately 20.58% of the shares of the Company through QingSongChou Holdings Corporation, Yang Group Holdings Limited, Yang Group Holdings Limited and other entities (assuming the over-allotment option is not exercised). Other major shareholders include Sunshine Life Insurance Co., Ltd. (approximately 7.74%), DTH Global Consumer Investment Co., Ltd. (approximately 3.04%), TDH Venture Capital Investment Limited (approximately 6.19%), among others.
AI AI Analysis AI interpretation deepseek-v4-pro · AI-generated
!
The following content is generated by an AI model based on historical IPO data. It does NOT constitute investment advice, solicitation, or recommendation. Past subscription patterns and post-listing performance do not guarantee future results. Data may contain inaccuracies — always verify against official HKEX filings and prospectuses before making any investment decision.

Market Sentiment

The IPO saw extreme demand with an oversubscription ratio of 1421.47x, reflecting intense market enthusiasm. The hit rate of 11.03% underscores the fierce competition for allocations. The offer price was fixed at HKD 22.68, though no initial range is available for comparison. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Tier Analysis

A striking tier inefficiency exists: the 甲尾 (200,000 lots) expected only 0.0687 lots, while the 乙头 (250,000 lots) received a higher 0.1562 expected lots, making the 甲尾 tier disproportionately unfavorable. This inversion suggests that larger B-tier applications gained a significant allocation advantage. Broker fee efficiency would likely favor the B-tier, though actual costs depend on individual fee structures. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Demographics

Demographic data appears incomplete, with reported total holders, mainland participation, and Hong Kong participation all at zero. Consequently, no analysis of investor geography or profile is possible for this IPO. This absence limits any assessment of regional demand dynamics. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

About this page

This page shows Qingsong Health (02661) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect